中医药
医学
柴胡
传统医学
奥司他韦
汤剂
不利影响
抗病毒药物
西医
药理学
H1N1流感
药品
内科学
2019年冠状病毒病(COVID-19)
替代医学
传染病(医学专业)
疾病
病理
作者
Jihong Yao,Haiyan Zhang,Li Ma,Xiaoli Mu,Yonghong Wang,LU Yuan-zhen,Pengfei Yu,Hong Dai
出处
期刊:PubMed
日期:2018-07-01
卷期号:31 (4(Special)): 1713-1717
被引量:9
摘要
The treatment of influenza A (H1N1) is mainly antiviral treatment, symptomatic treatment or traditional Chinese medicine treatment. Previous studies showed that the extract of Bupleurum has the functions of anti-inflammatory, antiviral, regulating the immune system and so on, which can be used to treat influenza. In this paper, we analyze the drug effect of bupleurum compound medicine, at the same time, using oseltamivir as control group. The results showed that the Chinese medicine chima qingwen decoction had certain antiviral effects. No adverse reactions occurred during the treatment period, and the overall effective rate was 93.3%. It shows that combination therapy of Chinese and Western medicine is feasible for mild cases of influenza A (H1N1). Therefore, the research and development of Chinese medicine preparations has positive research significance and sufficient market potential.
科研通智能强力驱动
Strongly Powered by AbleSci AI